Assistant Professor, Department of Medical Microbiology, College of Medicine, University of Manitoba Director, Clinical Microbiology Fellowship Training Program, College of Medicine, University of Manitoba Clinical Microbiologist, Diagnostic Services of Manitoba Degrees: M.Sc. [Microbiology] (Tübingen, Germany, 1993), Ph.D. [Microbiology] (Tübingen, Germany, 1997) Postdoctoral Fellowship: Novartis (Siena, Italy, 2002), Provincial Laboratory for Public Health (Edmonton, 2011) Professional Certifications/Awarded Fellowships: D[ABMM] (2013), F[CCM] (2013)

Antimicrobial resistance; diagnostic clinical microbiology; virulence of Helicobacter pylori

Mishra JP, Cohen D, Zamperone A, Nesic D, Muesch A, and Stein M. 2015. CagA of Helicobacter pylori interacts with and inhibits the Serine-Threonine Kinase PRK2. Cellular Microbiology. Nov; 17(11):1670-82 Mishra J, Ruggiero P., Bagnoli F., Rappuoli R., and Stein M.; 2015. Helicobacter pylori: The cancer bug (Chapter 10); ? Springer International Publishing Switzerland 2015; M.R. Shurin et al. (eds.), Infection and Cancer: Bi-Directorial Interactions, DOI 10.1007/978-3-319-20669-1 Stein M (2014) CagA, A Master Regulator of Host Protein Phosphorylation Events. SOJ Microbiol Infect Dis 2(1): 2. http://dx.doi.org/10.15226/sojmid.2013.00108 Stein M, Ruggiero P, Rappuoli R, Bagnoli F. 2013. Helicobacter pylori CagA: from pathogenic mechanisms to its use as an anti-cancer vaccine. Front. Immunol. - Immunotherapies and Vaccines, Volume 4|Article328|